Biogen Inc
(NAS:BIIB)
$
223.65
-2.81 (-1.24%)
Market Cap: 32.56 Bil
Enterprise Value: 38.43 Bil
PE Ratio: 27.92
PB Ratio: 2.13
GF Score: 68/100 - Q1 2024 Biogen Inc Earnings Call TranscriptApr 24, 2024$201.99 (+4.56%)Earnings
- Q4 2023 Biogen Inc Earnings Call TranscriptFeb 13, 2024$226.65 (-7.39%)Earnings
- Biogen Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Biogen Inc at Evercore ISI HealthCONx Conference TranscriptNov 28, 2023
- Q3 2023 Biogen Inc Earnings Call TranscriptNov 08, 2023$231.69 (-5.67%)Earnings
- Biogen Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Biogen Inc to Acquire Reata Pharmaceuticals Inc Call TranscriptJul 28, 2023
- Q2 2023 Biogen Inc Earnings Call TranscriptJul 25, 2023$270.31 (-2.42%)Earnings
- Q1 2023 Biogen Inc Earnings Call TranscriptApr 25, 2023$282.41 (-3.62%)Earnings
- Biogen Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Biogen Inc at Cowen Health Care Conference TranscriptMar 06, 2023
- Q4 2022 Biogen Inc Earnings Call TranscriptFeb 15, 2023$278.98 (-3.49%)Earnings
- Biogen Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- SAGE Therapeutics Inc and Biogen Inc to Discuss Potential Commercialization Plans for Zuranolone TranscriptDec 06, 2022
- Biogen Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Q3 2022 Biogen Inc Earnings Call TranscriptOct 25, 2022$273.56 (-0.39%)Earnings
- Biogen Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Biogen Inc Earnings Call TranscriptJul 20, 2022$207.49 (-5.80%)Earnings
- Q1 2022 Biogen Inc Earnings Call TranscriptMay 03, 2022$205.7 (-0.78%)Earnings
- Biogen Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Biogen Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Q4 2021 Biogen Inc Earnings Call TranscriptFeb 03, 2022$220.17 (-2.13%)Earnings
- Biogen Inc Analyst Q&A Call TranscriptJan 13, 2022
- Biogen Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Biogen Inc Engage and Emerge Trials at CTAD Call TranscriptNov 11, 2021
- Q3 2021 Biogen Inc Earnings Call TranscriptOct 20, 2021$266.57 (-0.58%)Earnings
- Biogen Inc to Present at the American Neurological Association Virtual Meeting TranscriptOct 17, 2021
- Biogen Inc Investor Day TranscriptSep 21, 2021
- Biogen Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Biogen Inc Earnings Call TranscriptJul 22, 2021$326.36 (+1.05%)Earnings
- Biogen Inc at SVB Leerink CNS Forum (Virtual) TranscriptJun 29, 2021
- Biogen Inc to Discuss the Approval of ADUHELM Call TranscriptJun 08, 2021
- Biogen Inc Annual Shareholders Meeting TranscriptJun 02, 2021
- Q1 2021 Biogen Inc Earnings Call TranscriptApr 22, 2021$259 (-4.02%)Earnings
- Biogen Inc at the Stifel 3rd Annual CNS Day TranscriptMar 31, 2021
- Biogen Inc Evaluation of aducanumab safety in early Alzheimer's disease at AD/PD TranscriptMar 13, 2021
- Biogen Inc Evaluation Of Aducanumab Efficacy And Safety In Early Alzheimer's Disease Discussion at AD/PD Conference Call TranscriptMar 13, 2021
- Biogen Inc Live Discussion of Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE at AD/PD TranscriptMar 10, 2021
- Biogen Inc Pre-Recorded Presentation of Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE at AD/PD TranscriptMar 10, 2021
- Biogen Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Biogen Inc Aducanumab Webinar Update TranscriptFeb 23, 2021
- Q4 2020 Biogen Inc Earnings Call TranscriptFeb 03, 2021$263.25 (-5.21%)Earnings
- Biogen Inc Corporate Call TranscriptJan 14, 2021
- Biogen Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Biogen Inc Conference Call to Discuss Collaboration with SAGE Therapeutics Inc TranscriptNov 30, 2020
- SAGE Therapeutics Inc Conference Call to Discuss Collaboration with Biogen Inc TranscriptNov 30, 2020
- Biogen Inc Aducanumab EMBARK study design and Q&A at CTAD 2020 TranscriptNov 04, 2020
- Q3 2020 Biogen Inc Earnings Call TranscriptOct 21, 2020$268.91 (+0.67%)Earnings
- Biogen Inc Emerging Science: Alzheimers, Migraine, ALS, CIDP TranscriptSep 23, 2020
- Biogen Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Biogen Inc Aducanumab Phase 3 Topline Results at AAIC (encore presentation and Q&A) TranscriptJul 29, 2020
- Q2 2020 Biogen Inc Earnings Call TranscriptJul 22, 2020$280.81 (+0.22%)Earnings
- Biogen Inc at Leerink CybeRx Series CNS Forum TranscriptJun 23, 2020
- Biogen Inc Annual Shareholders Meeting TranscriptJun 03, 2020
- Biogen Inc to Discuss Aducanumab Phase 3 Topline Results at AAN Presentation TranscriptMay 18, 2020
- Q1 2020 Biogen Inc Earnings Call TranscriptApr 22, 2020$298.01 (-9.42%)Earnings
- Biogen Inc Aducanumab Phase 3 Topline Results TranscriptApr 02, 2020
- Biogen Inc at Cowen HealthCare Conference TranscriptMar 02, 2020
- Q4 2019 Sangamo Therapeutics Inc Earnings and Collaboration Agreement with Biogen Inc Call TranscriptFeb 28, 2020
- Q4 2019 Biogen Inc Earnings Call TranscriptJan 30, 2020$277.53 (-1.77%)Earnings
- Biogen Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Biogen Inc Investor Q&A Call TranscriptDec 05, 2019
- Biogen Inc Aducanumab Phase 3 Topline Results TranscriptDec 05, 2019
- Biogen Inc at Evercore HealthCONx Conference TranscriptDec 03, 2019
- Q3 2019 Biogen Inc Earnings and Update on Aducanumab Call TranscriptOct 22, 2019
- Biogen Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Biogen Inc Earnings Call TranscriptJul 23, 2019$243.88 (+4.90%)Earnings
- Biogen Inc Annual Shareholders Meeting TranscriptJun 19, 2019
- Biogen Inc Webcast on ALS Portfolio Corporate Call TranscriptJun 05, 2019
- Biogen Inc at Sanford C Bernstein Strategic Decisions Conference TranscriptMay 30, 2019
- Q1 2019 Biogen Inc Earnings Call TranscriptApr 24, 2019$224.4 (-2.52%)Earnings
- Biogen Inc at Cowen Health Care Conference TranscriptMar 11, 2019
- Biogen Inc to Acquire Nightstar Therapeutics PLC to Establish Clinical Pipeline of Gene Therapy Candidates in Ophthalmology Call TranscriptMar 04, 2019
- Q4 2018 Biogen Inc Earnings Call TranscriptJan 29, 2019$334.48 (+1.35%)Earnings
Biogen Inc at Evercore HealthCONx Conference Transcript
Dec 03, 2019 / 04:45PM GMT
Release Date Price:
$290.7
(-0.58%)
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Okay. So thank you all for being here. Anirvan, thank you for making time. Just to level set for everyone. I was talking to Joe and the Biogen team, and most of the folks on the Biogen side have flown out to CTAD. So first of all, thank you for -- Biogen for still making time. Thank you, Anirvan, for coming up.
Questions & Answers
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Before we kick things off, Anirvan, since many of the investors on the street haven't had a chance to get to know you. Can you just tell us your role at the company, your background and also to level set how much we can or can't talk about aducanumab on this session?
Anirvan Ghosh
Biogen Inc. - SVP of Research and Early Development
Sure. Thanks for having me here. So just a couple of things. First of all, I might be making some forward-looking
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)